Medtec China 2019 to inaugurate on September 25 in Shanghai

Medtec China 2019 will be inaugurated on September 25 in Shanghai. Compared to last year, the scale of Me...

August 28, 2019 | Wednesday | News
Ascletis receives IND approval for its NASH drug

Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...

August 28, 2019 | Wednesday | News
HemaCare provides human derived biological material to China

US based HemaCare Corporation, a global leader and trusted brand in the customization of human-derived biological produc...

August 28, 2019 | Wednesday | News
Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019

ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announ...

August 27, 2019 | Tuesday | News
HKU unravels new findings on obesity-induced insulin resistance

A research team at the LKS Faculty of Medicine, The University of Hong Kong (HKUMed), has discovered the potentials of a...

August 27, 2019 | Tuesday | News
First patient dosed for Phase I/II trial of avapritinib in advanced GIST

CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II b...

August 26, 2019 | Monday | News
Chinese startup CareVoice closes series A round

The CareVoice, an international health insurtech company based in China, has announced that it has successfully rai...

August 23, 2019 | Friday | News
CStone registers for Phase I trial of CDK4/6 inhibitor CS3002 in Australia

CStone Pharmaceuticals, on 23 August 2019, announced that the Company has recently received ethics approval from the Hum...

August 23, 2019 | Friday | News
China approves AstraZeneca drug to treat anaemia in CKD patients

AstraZeneca has announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) ha...

August 23, 2019 | Friday | News
Innovent to develop & commercialize a novel diabetes medicine in China

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high-quality medicine...

August 22, 2019 | Thursday | News
CMAB, Kintor announce comprehensive collaboration

China based CMAB Biopharma Inc. (CMAB), a pure-play CDMO business in biologics and Suzhou Kintor Pharmaceuticals, Inc. (...

August 22, 2019 | Thursday | News
Alligator Bioscience signs antibody agreement for Greater China

Alligator Bioscience (ATORX), announces that a license agreement has been reached with Biotheus Inc. ("Biotheus"), a pri...

August 21, 2019 | Wednesday | News
Xynomic Research Institute designs potent RET Kinase Inhibitors

Xynomic Pharmaceuticals Holdings, Inc., a clinical stage US-China oncology drug development company, has announced that ...

August 20, 2019 | Tuesday | News
CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting

CStone Pharmaceuticals, on 20 August 2019, announced that an abstract on the company's CS1001-201 trial has been submitt...

August 20, 2019 | Tuesday | News
Sun Pharma to develop more generic products in China

Indian pharma major Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has grant...

August 19, 2019 | Monday | News
China NMPA approves Biktarvy to treat HIV-1 Infection

Gilead Sciences, Inc. has announced that the China National Medical Products Administration (NMPA) has ap...

August 16, 2019 | Friday | News
111, Inc. launches video interview series on China's Healthcare Landscape

Starting in August 2019, 111, Inc., a leading integrated online and offline healthcare platform, will launch "111 I...

August 16, 2019 | Friday | News
Tasly remains China's 2019 National Tech Innovation Demonstration Enterprise

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country...

August 16, 2019 | Friday | News